Biological characterization of glutaraldehyde-modified Parietaria judaica pollen extracts.
BACKGROUND
Allergoids are widely used in specific immunotherapy (SIT) for the treatment of IgE-mediated allergic diseases, but all techniques for standardization of conventional allergic extracts may not be appropriate for standardization of a glutaraldehyde (GA)-modified extract because of the unique characteristics of these extracts.


OBJECTIVE
To assess an accurate methodology for standardization of chemically modified extracts.


METHODS
GA-modified extracts from Parietaria judaica pollen were purified by diafiltration. Biochemical properties were investigated by determination of amino groups, chromatography, and SDS-PAGE. The IgE-binding activity was determined by skin prick test, enzyme allergosorbent test inhibition, basophil activation, and histamine release tests. Peripheral blood mononuclear cells (PBMCs) from P. judaica pollen-allergic subjects were stimulated with either native or allergoid extracts, and proliferation was measured.


RESULTS
Biochemical data indicated a high degree of allergen polymerization resulting in extract components higher than 100 kDa. IgE-binding activity, both in vivo and in vitro, was reduced by more than 99.8%. Both allergen and allergoid induced PBMC proliferation and synthesis of blocking IgG antibodies at similar rates. Moreover, no evidence of introduction of new determinants by chemical modification was found.


CONCLUSIONS
The preparation of GA-modified extracts by diafiltration is faster and more reliable than previous chromatographic methods. These modified extracts have drastically reduced their allergenicity while maintaining their immunogenicity, and therefore they can be used in safer and shortened schedules of SIT.
Ibarrola
I
I
Departamento de Investigación y Desarrollo, Bial-Arístegui, Bilbao, Spain.
Sanz
M L
ML
Gamboa
P M
PM
Mir
A
A
Benahmed
D
D
Ferrer
A
A
Arilla
M C
MC
Martínez
A
A
Asturias
J A
JA
D000293:Adolescent; D000328:Adult; D000485:Allergens / Q000276:immunology / Q000302:isolation & purification*; D000818:Animals; D003888:Desensitization, Immunologic; D005260:Female; D005374:Filtration; D005976:Glutaral; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology* / Q000628:therapy; D007159:Immunologic Tests; D008297:Male; D008875:Middle Aged; D032403:Parietaria; D010936:Plant Extracts / Q000276:immunology / Q000302:isolation & purification*; D011058:Pollen; D011817:Rabbits; D012882:Skin Tests
D000485:Allergens; D010936:Plant Extracts; D005976:Glutaral